Table 1 Demographic and clinical characteristics

Patients %(n)

44.8% (26)

55.1% (32)

Age (years)

48.5±11.2 (23.0 to 69.0)

48.6±13.9 (21.0 to 71.0)

Gender % (n)

Male

66.7% (18)

65.6% (21)

Female

33.3% (8)

34.4% (11)

Systemic disease % (n)

HTN

DM

Dyslipidemia

Depression

11.5% (3)

7.6 %(2)

11.5% (3)

1.7 %(1)

12.5% (4)

12.5% (4)

3.1% (1)

0% (0)

RD quadrant % (n)

Superior

0% (0)

3.1% (1)

Nasal

7.7% (2)

3.1% (1)

inferior

19.2% (5)

0% (0)

Temporal

3.8% (1)

21.9% (7)

Superonasal

11.5% (3)

9.4% (3)

Inferonasal

3.8% (1)

3.1% (1)

Inferotemporal

34.6% (9)

12.5% (4)

Superotemporal

19.2% (5)

46.9% (15)

Preoperative lens status

Phakic

53.8% (14)

71.9% (23)

Pseudophakic

42.3% (11)

25.0% (8)

Aphakic

3.8% (1)

3.1% (1)

Postoperative lens status

Phakic

3.8% (1)

18.8% (6)

Pseudophakic

92.3% (24)

78.1% (25)

Aphakic

3.8% (1)

3.1% (1)

Postoperative follow up (months)

Mean±SD

9.3±7.0

11.6±11.0

Median (Range)

6.5 (6.0 to 26.0)

7.5 (5.0 to 40.0)

Preoperative Central macular thickness (µm)

Mean±SD

288±62

277±25

Tamponade indication

Inferior break 46.1% (12)

Superior temporal break 46.9% (15)

Multiple break 38.4% (10)

Superior nasal break 34.3% (11)

Giant retinal break 7.7% (2)

Temporal break 12.5% (4)

Air travel 7.7% (2)

Nasal break 6.2.%. (2)

Silicone oil tamponade duration (months)

Mean±SD

8.1±3.4

Median (Range)

7.5 (4.0 to 18.0)